BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28010903)

  • 1. Disease and pharmacologic risk factors for first and subsequent episodes of equine laminitis: A cohort study of free-text electronic medical records.
    Welsh CE; Duz M; Parkin TDH; Marshall JF
    Prev Vet Med; 2017 Jan; 136():11-18. PubMed ID: 28010903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The corticosteroid laminitis story: 1. Duty of care.
    Dutton H
    Equine Vet J; 2007 Jan; 39(1):5-6. PubMed ID: 17228586
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence and clinical signs of owner-reported equine laminitis in a cohort of horses and ponies in Great Britain.
    Pollard D; Wylie CE; Newton JR; Verheyen KLP
    Equine Vet J; 2019 Sep; 51(5):587-594. PubMed ID: 30516850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does oral prednisolone treatment increase the incidence of acute laminitis?
    Jordan VJ; Ireland JL; Rendle DI
    Equine Vet J; 2017 Jan; 49(1):19-25. PubMed ID: 26713748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The corticosteroid laminitis story: 2. Science of if, when and how.
    Bailey SR; Elliott J
    Equine Vet J; 2007 Jan; 39(1):7-11. PubMed ID: 17228587
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of modifiable factors associated with owner-reported equine laminitis in Britain using a web-based cohort study approach.
    Pollard D; Wylie CE; Verheyen KLP; Newton JR
    BMC Vet Res; 2019 Feb; 15(1):59. PubMed ID: 30755193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cohort study of equine laminitis in Great Britain 2009-2011: estimation of disease frequency and description of clinical signs in 577 cases.
    Wylie CE; Collins SN; Verheyen KL; Newton JR
    Equine Vet J; 2013 Nov; 45(6):681-7. PubMed ID: 23489181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for equine laminitis: a case-control study conducted in veterinary-registered horses and ponies in Great Britain between 2009 and 2011.
    Wylie CE; Collins SN; Verheyen KL; Newton JR
    Vet J; 2013 Oct; 198(1):57-69. PubMed ID: 24070987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoids and laminitis in the horse.
    Johnson PJ; Slight SH; Ganjam VK; Kreeger JM
    Vet Clin North Am Equine Pract; 2002 Aug; 18(2):219-36. PubMed ID: 15635906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid-induced laminitis with hepatopathy in a Thoroughbred filly.
    Ryu SH; Kim BS; Lee CW; Yoon J; Lee YL
    J Vet Sci; 2004 Sep; 5(3):271-4. PubMed ID: 15365245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The corticosteroid laminitis story: 3. The clinician's viewpoint.
    Bathe AP
    Equine Vet J; 2007 Jan; 39(1):12-3. PubMed ID: 17228588
    [No Abstract]   [Full Text] [Related]  

  • 12. Intrasynovial triamcinolone treatment is not associated with incidence of acute laminitis.
    Haseler CJ; Jarvis GE; McGovern KF
    Equine Vet J; 2021 Sep; 53(5):895-901. PubMed ID: 33174264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for development of acute laminitis in horses during hospitalization: 73 cases (1997-2004).
    Parsons CS; Orsini JA; Krafty R; Capewell L; Boston R
    J Am Vet Med Assoc; 2007 Mar; 230(6):885-9. PubMed ID: 17362165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, matched case-control study of risk factors for equine laminitis.
    Alford P; Geller S; Richrdson B; Slater M; Honnas C; Foreman J; Robinson J; Messer M; Roberts M; Goble D; Hood D; Chaffin M
    Prev Vet Med; 2001 May; 49(3-4):209-22. PubMed ID: 11311954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severity and outcome of equine pasture-associated laminitis managed in first opinion practice in the UK.
    Menzies-Gow NJ; Stevens K; Barr A; Camm I; Pfeiffer D; Marr CM
    Vet Rec; 2010 Sep; 167(10):364-9. PubMed ID: 20817896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision-tree analysis of clinical data to aid diagnostic reasoning for equine laminitis: a cross-sectional study.
    Wylie CE; Shaw DJ; Verheyen KL; Newton JR
    Vet Rec; 2016 Apr; 178(17):420. PubMed ID: 26969668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age, breed, sex and seasonality as risk factors for equine laminitis.
    Polzer J; Slater MR
    Prev Vet Med; 1997 Jan; 29(3):179-84. PubMed ID: 9234403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of and risk factors for acute laminitis in horses treated with corticosteroids.
    Potter K; Stevens K; Menzies-Gow N
    Vet Rec; 2019 Jul; 185(3):82. PubMed ID: 31175222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of supporting limb laminitis in a UK equine practice and referral hospital setting between 2005 and 2013: implications for future epidemiological studies.
    Wylie CE; Newton JR; Bathe AP; Payne RJ
    Vet Rec; 2015 Jan; 176(3):72. PubMed ID: 25261271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggregate risk study of exposure to endophyte-infected (Acremonium coenophialum) tall fescue as a risk factor for laminitis in horses.
    Rohrbach BW; Green EM; Oliver JW; Schneider JF
    Am J Vet Res; 1995 Jan; 56(1):22-6. PubMed ID: 7695144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.